0 CHECKOUT

Archer Pharmaceuticals, Inc. - Product Pipeline Review - 2015

  • ID: 3230985
  • April 2015
  • 24 pages
  • Global Markets Direct
1 of 3

Archer Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Summary

This, ‘Archer Pharmaceuticals, Inc. - Product Pipeline Review - 2015’, provides an overview of the Archer Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Archer Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic READ MORE >

Note: Product cover images may vary from those shown
2 of 3

List of Tables
List of Figures
Archer Pharmaceuticals, Inc. Snapshot
Archer Pharmaceuticals, Inc. Overview
Key Information
Key Facts
Archer Pharmaceuticals, Inc. - Research and Development Overview
Key Therapeutic Areas
Archer Pharmaceuticals, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Archer Pharmaceuticals, Inc. - Pipeline Products Glance
Archer Pharmaceuticals, Inc. - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Archer Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
Archer Pharmaceuticals, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Archer Pharmaceuticals, Inc. - Drug Profiles
nilvadipine
Product Description
Mechanism of Action
R&D Progress
ARC-031
Product Description
Mechanism of Action
R&D Progress
ARC-050
Product Description
Mechanism of Action
R&D Progress
ARC-069
Product Description
Mechanism of Action
R&D Progress
Archer Pharmaceuticals, Inc. - Pipeline Analysis
Archer Pharmaceuticals, Inc. - Pipeline Products by Target
Archer Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
Archer Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
Archer Pharmaceuticals, Inc. - Recent Pipeline Updates
Archer Pharmaceuticals, Inc. - Dormant Projects
Archer Pharmaceuticals, Inc. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Archer Pharmaceuticals, Inc., Key Information
Archer Pharmaceuticals, Inc., Key Facts
Archer Pharmaceuticals, Inc. - Pipeline by Indication, 2015
Archer Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
Archer Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
Archer Pharmaceuticals, Inc. - Phase III, 2015
Archer Pharmaceuticals, Inc. - Phase I, 2015
Archer Pharmaceuticals, Inc. - Preclinical, 2015
Archer Pharmaceuticals, Inc. - Pipeline by Target, 2015
Archer Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015
Archer Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015
Archer Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015
Archer Pharmaceuticals, Inc. - Dormant Developmental Projects,2015

List of Figures
Archer Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
Archer Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
Archer Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2015
Archer Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015
Archer Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.